OUR INVESTMENTS
HEBECELL CORP
Lead investor.
Lead investor.
HebeCell develops scalable, off-the-shelf pluripotent-stem-cell-derived natural-killer-cell technology and related cell-production services.
LIFETECH SCIENTIFIC CORPORATION
Co-lead investor in a spinoff deal of a major US company.
Co-lead investor in a spinoff deal of a major US company.
LifeTech Scientific is an interventional medical-technology company with structural-heart and peripheral-vascular solutions.
MEDGRO BIO INC
Lead investor.
Lead investor.
Medgro Bio is a plant-biotechnology company using proprietary technologies to improve plant growth and yield.
ELIXELL THERAPEUTICS
Lead investor.
Lead investor.
Elixell Therapeutics focuses on next-generation drug discovery and development using artificial intelligence, digital chemistry, quantum physics, and robotics.
CYTEK BIOSCIENCES, INC.
Lead investor.
Lead investor.
Cytek Biosciences provides full-spectrum flow-cytometry instruments, reagents, software, and services for cell analysis.
ONCOIMMUNE, INC.
Acquired by Merck in 2020.
Acquired by Merck in 2020.
OncoImmune was a privately held clinical-stage biopharmaceutical company.
STELLAROMICS INC
Co-lead investor with Bayshore Global.
Co-lead investor with Bayshore Global.
Stellaromics develops an integrated platform for automated 3D spatial multi-omics in thick tissue.